Systemic inflammation induces brain neuronal inflammation, in turn causing acute
cognitive disorders. Furthermore, neuronal inflammation is one cause of postoperative
cognitive disorder (POCD) and delirium. However, no sufficiently established
pharmacological treatment is available for neurocognitive inflammation. This study
evaluated the possible neuroprotective effects of preconditioning with sevoflurane
anesthesia on cognition and neuroinflammatory changes in an animal model of
lipopolysaccharide (LPS)-induced systemic inflammation. Adult mice were randomly divided
into (1) control, (2) 2% sevoflurane preconditioning for 1 h, (3) intraperitoneal 5 mg/kg
LPS injection, and (4) 2% sevoflurane preconditioning for 1 h + LPS injection groups. At
24 h after 5 mg/kg LPS injection, microglial activation based on ionized calcium-binding
adapter molecule 1 (Iba-1) expression in the hippocampus was determined using
immunostaining and immunoblotting. IL-1β and IL-6 immunoblotting were used as inflammation
markers, and β-site of amyloid precursor protein cleaving enzyme 1 (BACE1) immunoblotting
was performed to evaluate amyloid β-protein (Aβ) accumulation. Long-term cognitive
impairment was evaluated using fear conditioning tests. Intraperitoneal LPS increased
levels of Iba-1 (150%), inflammation markers (160%), and Aβ accumulation (350%), and
sevoflurane preconditioning suppressed these increases. Systemic LPS caused learning
deficits. Sevoflurane also maintained long-term memory in mice receiving LPS injection.
Sevoflurane preconditioning prevented long-term memory impairment in the mouse model
administered systemic LPS by decreasing excessive microglial activation, inflammation, and
Aβ accumulation. This study supports the hypothesis that sevoflurane preconditioning might
also be beneficial for neuronal inflammation. Sevoflurane might be beneficial for reducing
delirium and POCD.